Cardiac amyloidosis in patients undergoing aortic valve replacement for aortic stenosis

29 August 2020 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Shigeru Fukuzawa

Funabashi Municipal Medical Center, Funabashi (Japan)

6 More presentations in this session

Presentation thumbnail

The GLP-1 receptor agonist Semaglutide decreases vascular inflammation in a rabbit model of advanced atherosclerosis

Doctor J. Kildevang Jensen (Gentofte, DK)

Abstract Slides

Presentation thumbnail

High-risk plaque burdens myocardial flow reserve in intermediate coronary artery disease: hybrid analysis of 13N-ammonia PET and coronary CT angiography.

Doctor A. Yamamoto (Shinjyuku, JP)

Abstract Slides

Presentation thumbnail

Prognostic role of positron emission tomography in patients with known or suspected cardiac sarcoidosis. a systematic review and meta-analysis

Doctor K. Bhatia (New York, US)

Abstract Slides

Presentation thumbnail

Splenic switch off as a novel marker for adenosine response in 13N-ammonia PET myocardial perfusion imaging - a pilot study.

Doctor A. Bakula (Bern, CH)

Abstract Slides

Presentation thumbnail

Prediction for cardiac prognosis in patients with congestive heart failure by machine learning on dual-isotope myocardial semiconductor SPECT

Doctor M. Shimizu (Yokohama, JP)

Abstract Slides

Access the full session

Session thumbnail

The 3I Role of Metabolic Imaging: Ischemia, Infection and Inflammation

The Event

ESC Congress 2020

29 August - 1 September 2020

You may be interested in

Congress Presentation

My Top 5 Nuclear Cardiology Papers of 2025

Congress Presentation

Novel PET tracers: paving the way for accessible cardiac PET

Congress Presentation

What comes next in nuclear cardiology?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources